Medicinal Products

DICLOFENAC CRISTERS 1%

Generic drug from Voltarene Emulgel
Therapeutic class: Anti-inflammatories
Active ingredients: [DiclofÚnac, 4407]
laboratory: Cristers

Gel
box of 1 tube of 100 g
All forms

Indication

Tendinitis of the upper and lower limbs.

Postoperative and post-traumatic afferents.

Symptomatic treatment of painful osteoarthritis of the fingers and knees.

Dosage DICLOFENAC CRISTERS 1% gel boast of 1 tube of 100 g

Tendinitis of the upper and lower limbs.

Postoperative and post-traumatic afferents.

Symptomatic treatment of painful osteoarthritis of the fingers and knees.

Against indications

This medication is contraindicated in the following cases:

From the beginning of the 6th month of pregnancy (see section on Pregnancy and lactation ),

Allergy to diclofenac or substances of similar activity such as other nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin,

Allergy to any of the excipients,

Skin lesions, whatever the lesion: oozing dermatoses, eczema, infected lesion, burns or sores.

Adverse effects Diclofenac Cristers

Frequent cases

Cutaneous reactions: rashes, eczema, asthma, dermatitis (including contact dermatitis).

Rare cases

Cutaneous Reactions: Bullous dermatosis. Associated pruritus is sometimes observed.

Very rare cases and isolated cases

Cutaneous Ruptures: pustular rash, urticaria, purpura, local ulcerations.

Reactions of hypersensitivity; angioneurotic edema (Quincke oedîme).

Respiratory problems: The onset of asthma attack may be related in some subjects to an allergy to aspirin or to an NSAID. In this case, this medicine is contraindicated.

Other skin reactions: Isolated cases of photosensitivity.

Other systemic effects of NSAIDs

They are a function of the transdermal passage of the active ingredient and therefore the amount of gel applied, the treated surface, the degree of integrity of the skin, the duration of treatment and the use or not of an occlusive dressing (digestive effects, renal).

Declaration of suspected undesirable effects

The declaration of undesirable effects suspected after authorization of the drug is important. It allows continuous monitoring of the beneficial / risk ratio of the drug. Healthcare professionals declare any suspected adverse effects via the national reporting system: National Agency of Safety of Medicines and Health Products (Ansm) and Network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts

Category Medicinal Products, Next Article